Table 4. Trend of serum CEA level before and after neoadjuvant erlotinib treatment.
Estimate of change in CEA level from baseline after 4 weeks. Between‐group difference in change was −53%; p = .031.
Abbreviations: CEA, carcinoembryonic antigen; EGFR TKI, epidermal growth factor receptor tyrosine kinase inhibitor; SD, standard deviation.